[HTML][HTML] The current burden of carbapenemases: review of significant properties and dissemination among gram-negative bacteria

D Hammoudi Halat, C Ayoub Moubareck - Antibiotics, 2020 - mdpi.com
Carbapenemases are β-lactamases belonging to different Ambler classes (A, B, D) and can
be encoded by both chromosomal and plasmid-mediated genes. These enzymes represent …

Antimicrobial resistance in ICUs: an update in the light of the COVID-19 pandemic

R Cantón, D Gijón… - Current opinion in critical …, 2020 - journals.lww.com
The increase of antimicrobial resistance in ICUs is mainly due to the spread of HiRCs and is
exemplified with the ESKAPE Gram-negative microorganisms. The COVID-19 pandemic …

[HTML][HTML] Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit

Y Jiang, Y Ding, Y Wei, C Jian, J Liu… - Frontiers in microbiology, 2022 - frontiersin.org
Carbapenem-resistant Acinetobacter baumannii (CRAB) has become one of the leading
causes of healthcare-associated infections globally, particularly in intensive care units …

[HTML][HTML] Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility

MM Al-Shamiri, S Zhang, P Mi, Y Liu, M Xun… - Microbial …, 2021 - Elsevier
Acinetobacter baumannii is an important pathogen in clinical. The factors of biofilm
formation, antibiotic resistance and motility contribute great to A. baumannii in persisting in …

[HTML][HTML] Acinetobacter baumannii: an evolving and cunning opponent

J Shi, J Cheng, S Liu, Y Zhu, M Zhu - Frontiers in Microbiology, 2024 - frontiersin.org
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing
nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is …

[HTML][HTML] Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study

P Khuntayaporn, P Kanathum, J Houngsaitong… - Annals of clinical …, 2021 - Springer
Background Acinetobacter baumannii has emerged as one of the common multidrug
resistance pathogens causing hospital-acquired infections. This study was conducted to …

[HTML][HTML] Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?

F Medioli, E Bacca, M Faltoni, GJ Burastero, S Volpi… - Antibiotics, 2022 - mdpi.com
Background: Despite the global efforts to antagonize carbapenem-resistant Acinetobacter
baumannii (CRAB) spreading, it remains an emerging threat with a related mortality …

[HTML][HTML] Molecular epidemiology of Acinetobacter baumannii complex causing invasive infections in Korean children during 2001–2020

HM Kang, KW Yun, EH Choi - Annals of Clinical Microbiology and …, 2023 - Springer
Background Acinetobacter baumannii (AB) has emerged as one of the most problematic
pathogens affecting critically ill patients. This study aimed to investigate the longitudinal …

[HTML][HTML] A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit

M Meschiari, JM Lòpez-Lozano, V Di Pilato… - … Resistance & Infection …, 2021 - Springer
Abstract Background Carbapenem-resistant Acinetobacter baumannii (CRAB) infection
outbreaks are difficult to control and sometimes require cohorting of CRAB-positive patients …

[HTML][HTML] Estimation, evaluation and characterization of carbapenem resistance burden from a tertiary care hospital, Pakistan

AJ Gondal, N Choudhry, H Bukhari, Z Rizvi, S Jahan… - Antibiotics, 2023 - mdpi.com
Carbapenem resistance has become major concern in healthcare settings globally;
therefore, its monitoring is crucial for intervention efforts to halt resistance spread. During …